REGENERON PHARMACEUTICALS, INC.·4

Aug 14, 4:01 PM ET

STAHL NEIL 4

4 · REGENERON PHARMACEUTICALS, INC. · Filed Aug 14, 2024

Insider Transaction Report

Form 4
Period: 2024-08-13
STAHL NEIL
SVP Res and Dev Sciences
Transactions
  • Gift

    Common Stock

    2024-08-1350049,599 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,849
  • Common Stock

    (indirect: By Trust)
    4,605

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT